• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Dok2和RasGAP在CD200受体介导的人类髓样细胞调节中的重要作用。

Essential roles for Dok2 and RasGAP in CD200 receptor-mediated regulation of human myeloid cells.

作者信息

Mihrshahi Robin, Barclay A Neil, Brown Marion H

机构信息

Sir William Dunn School of Pathology, University of Oxford, Oxford, United Kingdom.

出版信息

J Immunol. 2009 Oct 15;183(8):4879-86. doi: 10.4049/jimmunol.0901531. Epub 2009 Sep 28.

DOI:10.4049/jimmunol.0901531
PMID:19786546
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2788151/
Abstract

The CD200 receptor (CD200R) acts as a negative regulator of myeloid cells by interacting with its widely expressed ligand CD200. Using mutants expressed in U937 cells, we show that inhibition is mediated by the PTB domain binding motif (NPLY) in the receptor's cytoplasmic region. The adaptor protein downstream of tyrosine kinase 2 (Dok2) bound directly to the phosphorylated NPLY motif with a 10-fold higher affinity (K(D) of approximately 1 microM at 37 degrees C) than the closely related Dok1. Both of these proteins have been suggested to play a role in CD200R signaling in murine cells. Dok2 was phosphorylated in response to CD200R engagement and recruited RAS p21 protein activator 1 (RasGAP). Knockdown of Dok2 and RasGAP by RNA interference revealed that these proteins are required for CD200R signaling, while knockdown of Dok1 and the inositol 5-phosphatase SHIP did not affect CD200R-mediated inhibition. We conclude that CD200R inhibits the activation of human myeloid cells through direct recruitment of Dok2 and subsequent activation of RasGAP, which distinguishes this receptor from the majority of inhibitory receptors that utilize ITIMs and recruit phosphatases.

摘要

CD200受体(CD200R)通过与其广泛表达的配体CD200相互作用,充当髓样细胞的负调节因子。利用在U937细胞中表达的突变体,我们发现抑制作用是由受体胞质区域中的PTB结构域结合基序(NPLY)介导的。酪氨酸激酶2下游的衔接蛋白(Dok2)直接与磷酸化的NPLY基序结合,其亲和力比密切相关的Dok1高10倍(37℃时的解离常数K(D)约为1 microM)。这两种蛋白都被认为在小鼠细胞的CD200R信号传导中发挥作用。Dok2在CD200R参与时发生磷酸化,并募集RAS p21蛋白激活剂1(RasGAP)。通过RNA干扰敲低Dok2和RasGAP表明,这些蛋白是CD200R信号传导所必需的,而敲低Dok1和肌醇5-磷酸酶SHIP并不影响CD200R介导的抑制作用。我们得出结论,CD200R通过直接募集Dok2和随后激活RasGAP来抑制人髓样细胞的激活,这使该受体与大多数利用免疫受体酪氨酸抑制基序(ITIM)并募集磷酸酶的抑制性受体有所不同。

相似文献

1
Essential roles for Dok2 and RasGAP in CD200 receptor-mediated regulation of human myeloid cells.Dok2和RasGAP在CD200受体介导的人类髓样细胞调节中的重要作用。
J Immunol. 2009 Oct 15;183(8):4879-86. doi: 10.4049/jimmunol.0901531. Epub 2009 Sep 28.
2
Downstream of tyrosine kinase 1 and 2 play opposing roles in CD200 receptor signaling.酪氨酸激酶 1 和 2 的下游在 CD200 受体信号中发挥相反的作用。
J Immunol. 2010 Dec 15;185(12):7216-22. doi: 10.4049/jimmunol.1002858. Epub 2010 Nov 15.
3
Molecular mechanisms of CD200 inhibition of mast cell activation.CD200抑制肥大细胞活化的分子机制。
J Immunol. 2004 Dec 1;173(11):6786-93. doi: 10.4049/jimmunol.173.11.6786.
4
Identification of tyrosine residues crucial for CD200R-mediated inhibition of mast cell activation.鉴定对CD200R介导的肥大细胞活化抑制至关重要的酪氨酸残基。
J Leukoc Biol. 2006 Feb;79(2):363-8. doi: 10.1189/jlb.0705398. Epub 2005 Dec 5.
5
Differential role of Dok1 and Dok2 in TLR2-induced inflammatory signaling in glia.Dok1 和 Dok2 在 TLR2 诱导的神经胶质细胞炎症信号中的差异作用。
Mol Cell Neurosci. 2013 Sep;56:148-58. doi: 10.1016/j.mcn.2013.04.007. Epub 2013 May 7.
6
Downstream of kinase, p62(dok), is a mediator of Fc gamma IIB inhibition of Fc epsilon RI signaling.激酶下游的p62(dok)是FcγIIB抑制FcεRI信号传导的介质。
J Immunol. 2002 May 1;168(9):4430-9. doi: 10.4049/jimmunol.168.9.4430.
7
The roles of Dok family adapters in immunoreceptor signaling.Dok 家族衔接蛋白在免疫受体信号中的作用。
Immunol Rev. 2009 Nov;232(1):273-85. doi: 10.1111/j.1600-065X.2009.00844.x.
8
Dok2 mediates the CD200Fc attenuation of Aβ-induced changes in glia.Dok2 介导了 CD200Fc 对 Aβ诱导的神经胶质细胞变化的抑制作用。
J Neuroinflammation. 2012 May 29;9:107. doi: 10.1186/1742-2094-9-107.
9
Recombinant CD200 protein does not bind activating proteins closely related to CD200 receptor.重组CD200蛋白不与与CD200受体密切相关的激活蛋白结合。
J Immunol. 2005 Aug 15;175(4):2469-74. doi: 10.4049/jimmunol.175.4.2469.
10
Dissection of agonistic and blocking effects of CD200 receptor antibodies.CD200 受体抗体的激动和阻断作用的剖析。
PLoS One. 2013 May 14;8(5):e63325. doi: 10.1371/journal.pone.0063325. Print 2013.

引用本文的文献

1
CD200R1-CD200 checkpoint inhibits phagocytosis differently from SIRPα-CD47 to suppress tumor growth.CD200R1-CD200 检查点与 SIRPα-CD47 不同,它通过抑制吞噬作用来抑制肿瘤生长。
Nat Commun. 2025 Jun 3;16(1):5145. doi: 10.1038/s41467-025-60456-3.
2
CD200R blockade enhances anti-tumor immunity by unleashing NK and CD8 T cells in tumor.CD200R阻断通过释放肿瘤中的自然杀伤细胞和CD8 T细胞来增强抗肿瘤免疫力。
Acta Pharmacol Sin. 2025 May 6. doi: 10.1038/s41401-025-01556-0.
3
Bioinformatics-based identification of CTSS, DOK2, and ENTPD1 as potential blood biomarkers of schizophrenia.基于生物信息学鉴定组织蛋白酶S、DOK2和ENTPD1作为精神分裂症潜在的血液生物标志物。
BMC Psychiatry. 2025 Feb 19;25(1):157. doi: 10.1186/s12888-025-06512-0.
4
First-in-Human Study of 23ME-00610, an Antagonistic Antibody for Genetically Validated CD200R1 Immune Checkpoint, in Participants with Advanced Solid Malignancies.23ME - 00610(一种针对经基因验证的CD200R1免疫检查点的拮抗抗体)在晚期实体恶性肿瘤患者中的首次人体研究。
Cancer Res Commun. 2025 Jan 1;5(1):94-105. doi: 10.1158/2767-9764.CRC-24-0568.
5
Peripheral CD4 T cell phenotype and brain microglial activation associated with cognitive heterogeneity in aged rats.外周CD4 T细胞表型与老年大鼠认知异质性相关的脑小胶质细胞激活。
Immun Ageing. 2024 Nov 14;21(1):81. doi: 10.1186/s12979-024-00486-5.
6
Effects of Schistosoma haematobium infection and treatment on the systemic and mucosal immune phenotype, gene expression and microbiome: A systematic review.埃及血吸虫感染和治疗对全身和黏膜免疫表型、基因表达和微生物组的影响:系统评价。
PLoS Negl Trop Dis. 2024 Sep 9;18(9):e0012456. doi: 10.1371/journal.pntd.0012456. eCollection 2024 Sep.
7
CD200/CD200R: Bidirectional Role in Cancer Progression and Immunotherapy.CD200/CD200R:在癌症进展和免疫治疗中的双向作用
Biomedicines. 2023 Dec 16;11(12):3326. doi: 10.3390/biomedicines11123326.
8
Emerging Immune Checkpoint Molecules on Cancer Cells: CD24 and CD200.肿瘤细胞上新兴的免疫检查点分子:CD24 和 CD200。
Int J Mol Sci. 2023 Oct 11;24(20):15072. doi: 10.3390/ijms242015072.
9
Porcine Macrophage Markers and Populations: An Update.猪巨噬细胞标志物和群体:更新。
Cells. 2023 Aug 19;12(16):2103. doi: 10.3390/cells12162103.
10
Exploiting the CD200-CD200R immune checkpoint axis in multiple myeloma to enhance CAR T-cell therapy.利用多发性骨髓瘤中的 CD200-CD200R 免疫检查点轴增强 CAR T 细胞疗法。
Blood. 2024 Jan 11;143(2):139-151. doi: 10.1182/blood.2022018658.

本文引用的文献

1
p120-Ras GTPase activating protein (RasGAP): a multi-interacting protein in downstream signaling.p120-Ras鸟苷三磷酸酶激活蛋白(RasGAP):下游信号传导中的一种多相互作用蛋白。
Biochimie. 2009 Mar;91(3):320-8. doi: 10.1016/j.biochi.2008.10.010. Epub 2008 Oct 30.
2
Capns1, a new binding partner of RasGAP-SH3 domain in K-Ras(V12) oncogenic cells: modulation of cell survival and migration.Capns1,K-Ras(V12)致癌细胞中RasGAP-SH3结构域的新结合伴侣:对细胞存活和迁移的调节
Cell Signal. 2008 Nov;20(11):2119-26. doi: 10.1016/j.cellsig.2008.08.005. Epub 2008 Aug 13.
3
Immunoreceptor tyrosine-based inhibition motifs: a quest in the past and future.基于免疫受体酪氨酸的抑制基序:过去与未来的探索
Immunol Rev. 2008 Aug;224:11-43. doi: 10.1111/j.1600-065X.2008.00666.x.
4
Prospective of Ras signaling in stem cells.干细胞中Ras信号传导的前景。
Biol Chem. 2008 Jul;389(7):791-8. doi: 10.1515/BC.2008.104.
5
Characterization of the chicken CD200 receptor family.鸡CD200受体家族的特征描述。
Mol Immunol. 2008 Apr;45(7):2097-105. doi: 10.1016/j.molimm.2007.10.012. Epub 2007 Nov 19.
6
Co-expression of the toleragenic glycoprotein, CD200, with markers for cancer stem cells.耐受性糖蛋白CD200与癌症干细胞标志物的共表达。
Biochem Biophys Res Commun. 2007 Dec 28;364(4):778-82. doi: 10.1016/j.bbrc.2007.10.067. Epub 2007 Oct 25.
7
Direct and indirect interactions of the cytoplasmic region of CD244 (2B4) in mice and humans with FYN kinase.小鼠和人类中CD244(2B4)胞质区域与FYN激酶的直接和间接相互作用。
J Biol Chem. 2007 Aug 31;282(35):25385-94. doi: 10.1074/jbc.M704483200. Epub 2007 Jun 28.
8
CD200 expression on tumor cells suppresses antitumor immunity: new approaches to cancer immunotherapy.肿瘤细胞上的CD200表达抑制抗肿瘤免疫:癌症免疫治疗的新方法。
J Immunol. 2007 May 1;178(9):5595-605. doi: 10.4049/jimmunol.178.9.5595.
9
Dok-1 and Dok-2 are negative regulators of T cell receptor signaling.Dok-1和Dok-2是T细胞受体信号传导的负调节因子。
Int Immunol. 2007 Apr;19(4):487-95. doi: 10.1093/intimm/dxm015. Epub 2007 Feb 27.
10
CD200 as a prognostic factor in acute myeloid leukaemia.CD200作为急性髓系白血病的一个预后因素。
Leukemia. 2007 Mar;21(3):566-8. doi: 10.1038/sj.leu.2404559. Epub 2007 Jan 25.